Fibrillary glomerulonephritis associated with essential thrombocytosis.

Abstract:

:A 68-year-old man with a 30-year history of essential thrombocytosis developed nephrotic syndrome. Renal biopsy showed massive deposits of Congo red-negative periodic acid Schiff (PAS)-positive substance in the mesangium and capillary wall that was positive for IgG. Electron microscopic examination revealed 10- to 20-nm fibrils in the deposits, and there was no other organ involvement; thus, we diagnosed fibrillary glomerulonephritis. This is the first report of a case of fibrillary glomerulonephritis associated with essential thrombocytosis.

journal_name

Clin Exp Nephrol

authors

Asaba K,Tojo A,Onozato ML,Mimura N,Kido M,Goto A,Endo H,Fujita T

doi

10.1007/s10157-003-0250-2

subject

Has Abstract

pub_date

2003-12-01 00:00:00

pages

296-300

issue

4

eissn

1342-1751

issn

1437-7799

journal_volume

7

pub_type

杂志文章
  • Cost-effectiveness of chronic kidney disease mass screening test in Japan.

    abstract:BACKGROUND:Chronic kidney disease (CKD) is a significant public health problem. Strategy for its early detection is still controversial. This study aims to assess the cost-effectiveness of population strategy, i.e. mass screening, and Japan's health checkup reform. METHODS:Cost-effectiveness analysis was carried out t...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-011-0567-1

    authors: Kondo M,Yamagata K,Hoshi SL,Saito C,Asahi K,Moriyama T,Tsuruya K,Yoshida H,Iseki K,Watanabe T

    更新日期:2012-04-01 00:00:00

  • Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

    abstract:BACKGROUND:Two randomized, double-blind, placebo-controlled trials (EPPIC-1 and EPPIC-2) investigated the efficacy and safety of AST-120, an oral spherical carbon adsorbent, in adults with chronic kidney disease (CKD). While the benefit of adding AST-120 to standard therapy was not supported by these trials, we perform...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s10157-017-1447-0

    authors: Schulman G,Berl T,Beck GJ,Remuzzi G,Ritz E,Shimizu M,Kikuchi M,Shobu Y

    更新日期:2018-04-01 00:00:00

  • Biological variation of procalcitonin levels in hemodialysis patients.

    abstract:BACKGROUND:There is no obvious evidence regarding biological variation of procalcitonin (PCT) levels in hemodialysis (HD) patients without infections. The aim of this study was to determine the within- and between-person biological variation of PCT levels in HD patients without infections. METHODS:A multicenter, prosp...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s10157-018-1639-2

    authors: Kubo S,Iwasaki M,Horie M,Matsukane A,Hayashi T,Tanaka Y,Hase H,Joki N

    更新日期:2019-03-01 00:00:00

  • A potentially crucial role of the PKD1 C-terminal tail in renal prognosis.

    abstract:BACKGROUND:Autosomal dominant polycystic disease (ADPKD) often results in renal failure. Recently, allelic influences of PKD1 mutation types on renal survival were extensively investigated. Here, we analyzed integrated influences of PKD1 mutation types and positions on renal survival. METHODS:We included 338 (82 pedig...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s10157-017-1477-7

    authors: Higashihara E,Horie S,Kinoshita M,Harris PC,Okegawa T,Tanbo M,Hara H,Yamaguchi T,Shigemori K,Kawano H,Miyazaki I,Kaname S,Nutahara K

    更新日期:2018-04-01 00:00:00

  • Tubulointerstitial nephritis and uveitis syndrome associated with hyperthyroidism.

    abstract::We report a 17-year-old male patient with tubulointerstitial nephritis and uveitis (TINU) associated with hyperthyroidism. He presented with a 2-month history of fatigue, loss of appetite, low-grade fever, and a 12-kg weight loss when he was admitted to our hospital. He had iritis, which was complicated by fibrin in t...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-006-0423-x

    authors: Ebihara I,Hirayama K,Usui J,Seki M,Higuchi F,Oteki T,Kobayashi M,Yamagata K

    更新日期:2006-09-01 00:00:00

  • Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib.

    abstract::A 52-year-old Japanese female was admitted to our hospital for microhematuria, proteinuria and progressive renal dysfunction. Two years prior to admission, she was diagnosed with lung adenocarcinoma and multiple bone and brain metastases, and was treated with gefitinib (250 mg/day). Treatment for 6 months induced part...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-008-0066-1

    authors: Masutani K,Fujisaki K,Maeda H,Toyonaga J,Inoshima I,Takayama K,Katafuchi R,Hirakata H,Tsuruya K,Iida M

    更新日期:2008-10-01 00:00:00

  • Rituximab for nephrotic syndrome in children.

    abstract::Idiopathic nephrotic syndrome is the most common chronic glomerular disease in children. At least 20 % of children with this syndrome show frequent relapses and/or steroid dependence during or after immunosuppressive therapies, a condition defined as complicated frequently relapsing/steroid-dependent nephrotic syndrom...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s10157-016-1313-5

    authors: Iijima K,Sako M,Nozu K

    更新日期:2017-04-01 00:00:00

  • Cardiovascular remodeling during long-term nocturnal home hemodialysis.

    abstract:BACKGROUND:Cardiovascular disease is the leading cause of morbidity and mortality in patients with kidney failure. Nocturnal home hemodialysis (NHD) is a form of kidney replacement therapy whereby hemodialysis is performed for at least 6-h overnight, at least 4 days per week. Little is known about the effects of NHD on...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-014-0992-z

    authors: Friesen T,Jassal DS,Zhu M,Eng F,Rigatto C,Tangri N,Sood MM,Karlstedt E,Premecz S,Komenda P

    更新日期:2015-06-01 00:00:00

  • Churg-Strauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis, which developed during therapy with a leukotriene receptor antagonist.

    abstract::A 77-year-old Japanese female developed Churg-Strauss syndrome (CSS), showing fever and numbness in bilateral hands. She was being treated for bronchial asthma with combination inhalant of corticosteroid with beta(2)-agonist, and an oral leukotriene receptor antagonist (LTRA), montelukast, for 15 months. She presented...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-010-0313-0

    authors: Kanda T,Tanio H,Wu C,Nishihara H,Nogaki F,Ono T

    更新日期:2010-12-01 00:00:00

  • Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.

    abstract:BACKGROUND AND AIM:The infusion of chronic angiotensin II (Ang II) has been shown to promote renal interstitial fibrosis. To evaluate the pathophysiological significance of the natriuretic peptide-GC-A system, we infused Ang II (1.0 mg/kg/day) in GC-A-deficient mice (GC-A-KO). METHODS:We used 5 groups (Wild-Saline n =...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-014-0982-1

    authors: Yoshihara F,Tokudome T,Kishimoto I,Otani K,Kuwabara A,Horio T,Kawano Y,Kangawa K

    更新日期:2015-04-01 00:00:00

  • Nicorandil suppresses urinary protein excretion and activates eNOS in Dahl salt-sensitive hypertensive rats.

    abstract:BACKGROUND:Hypertension is a risk factor common to both chronic kidney disease and cardiovascular disease. Nicorandil is widely used for the treatment of angina. We investigated the benefits of nicorandil with respect to renal dysfunction in Dahl salt-sensitive hypertensive (DS) rats. METHOD:DS rats were fed a high-sa...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-014-0998-6

    authors: Tashiro Y,Yogo K,Serizawa K,Endo K

    更新日期:2015-06-01 00:00:00

  • Hypocomplementemia and membranoproliferative glomeruloneophritis in children.

    abstract:BACKGROUND:The incidence of hypocomplementemia detected in the school urinary screening program in Kanagawa Prefecture, Japan, and the number of new patients with membranoproliferative glomerulonephritis (MPGN) diagnosed in our institution were decreasing during the period between 1974 and 1997. Follow-up of this study...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-004-0330-y

    authors: Iitaka K,Nakamura S,Moriya S,Koshino H,Iwanami N,Sakai T,Motoyama O

    更新日期:2005-03-01 00:00:00

  • Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study.

    abstract:BACKGROUND:The present study aimed to clarify the beneficial effect of allopurinol on cardiovascular morbidity and mortality in a cohort of hypertensive nephropathy patients with impaired kidney function. METHODS:One hundred and seventy-eight patients diagnosed with hypertensive nephropathy and presenting with impaire...

    journal_title:Clinical and experimental nephrology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1007/s10157-012-0742-z

    authors: Terawaki H,Nakayama M,Miyazawa E,Murata Y,Nakayama K,Matsushima M,Miyazaki M,Sato H,Sato M,Sato T,Taguma Y,Ito S

    更新日期:2013-08-01 00:00:00

  • Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

    abstract:BACKGROUND:The present study was conducted to clarify the clinical risk factors related to the development of encapsulating peritoneal sclerosis (EPS), which is one of the most serious complications in patients undergoing peritoneal dialysis (PD). METHODS:The records of 78 patients with a history of PD treatment, incl...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-005-0349-8

    authors: Yamamoto R,Otsuka Y,Nakayama M,Maruyama Y,Katoh N,Ikeda M,Yamamoto H,Yokoyama K,Kawaguchi Y,Matsushima M

    更新日期:2005-06-01 00:00:00

  • Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.

    abstract::Waldenström's macroglobulinemia is rare lymphoproliferative disorder characterized by the presence of a monoclonal IgM paraproteinemia. Cryoglobulinemia is a common sequela of Waldenström's macroglobulinemia present in 8-18% of the patients. Cryoglobulinemia has also been described as occurring after treatment with ri...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-008-0042-9

    authors: Shaikh A,Habermann TM,Fidler ME,Kumar S,Leung N

    更新日期:2008-08-01 00:00:00

  • Adrenomedullin (AM) and receptor-activity-modifying proteins in glomeruli with Thy.1 glomerulonephritis.

    abstract:BACKGROUND:Adrenomedullin (AM) has antiproliferative and proapoptotic effects on mesangial cells in culture, but the regulation of AM and its receptors in glomeruli with glomerulonephritis have not been clarified. METHODS:We examined sequential changes in the mRNA expression of AM and its receptors (receptor-activity-...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-004-0309-8

    authors: Matsumoto M,Fujimoto S,Iwatsubo S,Sato Y,Hara S,Kitamura K,Eto T

    更新日期:2004-12-01 00:00:00

  • CD147 expression in peritoneal injury.

    abstract:BACKGROUND:Peritoneal injury is an important cause of technical failure of long-term peritoneal dialysis (PD). Encapsulating peritoneal sclerosis (EPS) is a severe complication of long-term PD with potentially life threatening consequences. CD147 is a glycoprotein with diverse functions including modulation of extracel...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-017-1390-0

    authors: Seeger H,Latus J,Kitterer D,Alscher MD,Biegger D,Chen J,Edenhofer I,Wüthrich RP,Segerer S

    更新日期:2017-12-01 00:00:00

  • The need for disruptive innovation in acute kidney injury.

    abstract::Acute kidney injury (AKI) is a threatening medical condition associated with poor outcomes at different settings. The development of standardized diagnostic criteria and new biomarkers addressed significant clinical impacts of AKI and the need for an early AKI detection, respectively. There have been some breakthrough...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s10157-020-01920-w

    authors: Doi K

    更新日期:2020-11-01 00:00:00

  • The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor.

    abstract:BACKGROUND:Dotinurad, a novel selective urate reabsorption inhibitor (SURI), increases urinary uric acid excretion. The aim of this study is to examine the pharmacokinetics, pharmacodynamics, and safety of dotinurad according to the type of hyperuricemia, with or without concomitant use of xanthine oxidase inhibitor, i...

    journal_title:Clinical and experimental nephrology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s10157-019-01817-3

    authors: Okui D,Sasaki T,Fushimi M,Ohashi T

    更新日期:2020-03-01 00:00:00

  • Involvement of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy.

    abstract::The manifestation of diabetic nephropathy may be a consequence of the actions of certain cytokines and growth factors. Prominent among them is transforming growth factor-β (TGF-β), which promotes renal cell hypertrophy and stimulates extracellular matrix accumulation, the two hallmarks of diabetic renal disease. In ex...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s101570200021

    authors: Ziyadeh FN,Isono M,Chen S

    更新日期:2002-09-01 00:00:00

  • Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy.

    abstract:BACKGROUND:Analyses of selected cases suggest that immunosuppressive treatment could reduce proteinuria and delay the progression of immunoglobulin A nephropathy (IgAN). The aim of this study was to examine the long-term effectiveness of this therapy on the clinical course of IgAN. We also examined the relationship bet...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-008-0045-6

    authors: Oshima S,Kawamura O

    更新日期:2008-08-01 00:00:00

  • Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study.

    abstract:BACKGROUND:Hyperuricemia is an established risk factor for cardiovascular events and mortality. This study investigated the association between serum uric acid and the incidence of nonfatal stroke in a Japanese community-based population. METHODS:We used a nationwide database of 155,322 subjects (aged 40-73, male 39 %...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-016-1311-7

    authors: Kamei K,Konta T,Hirayama A,Ichikawa K,Kubota I,Fujimoto S,Iseki K,Moriyama T,Yamagata K,Tsuruya K,Narita I,Kondo M,Shibagaki Y,Kasahara M,Asahi K,Watanabe T

    更新日期:2017-06-01 00:00:00

  • Pathology of glomerular lipidosis.

    abstract::Glomerular lipid deposition is sometimes associated with a particular kind of lipid metabolism disturbance. Ultrastructural analyses using electron microscopy often indicate a disease-specific aspect of intraglomerular lipid distribution. ...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s10157-013-0882-9

    authors: Sato H,Takahashi N,Sato E,Kisu K,Ito S,Saito T

    更新日期:2014-04-01 00:00:00

  • The association between urinary liver-type fatty acid-binding protein and chronic kidney disease classification in HIV-infected Japanese patients.

    abstract:BACKGROUND:Renal dysfunction is recognized with increasing frequency among the noninfectious comorbidities associated with human immunodeficiency virus (HIV) infection. Urinary liver-type fatty acid-binding protein (L-FABP) has been shown to be a new biomarker to screen for not only tubulointerstitial damage but also k...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-016-1347-8

    authors: Hikasa S,Yasuda M,Hideta K,Kawakami M,Higasa S,Sawada A,Tokugawa T,Kimura T

    更新日期:2017-12-01 00:00:00

  • Aliskiren-associated acute kidney injury in a patient with pre-existing chronic kidney disease and dilated cardiomyopathy.

    abstract::We report a case of acute kidney injury (AKI) caused by a novel direct renin inhibitor, aliskiren. A 43-year-old Japanese man with dilated cardiomyopathy on cardiac resynchronization therapy with defibrillator and chronic kidney disease (CKD) was started on aliskiren in addition to enalapril, carvedilol, furosemide, a...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-011-0566-2

    authors: Yamauchi J,Shibagaki Y,Uehara K,Yasuda T,Kimura K

    更新日期:2012-04-01 00:00:00

  • Evaluation of hematuria using the urinary albumin-to-total-protein ratio to differentiate glomerular and nonglomerular bleeding.

    abstract:BACKGROUND:Depending on the etiology and pathophysiology of hematuria, urinary bleeding is classified as glomerular hematuria or nonglomerular hematuria. Nephritis is usually detected by the presence of proteinuria, especially elevated albumin excretion. In this study, we report on the use of the urinary albumin-to-tot...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-006-0451-6

    authors: Ohisa N,Kanemitsu K,Matsuki R,Suzuki H,Miura H,Ohisa Y,Yoshida K,Kaku M,Sato H

    更新日期:2007-03-01 00:00:00

  • Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation.

    abstract:BACKGROUND:Mizoribine (MZR) was approved in 1984 in Japan for the suppression of rejection in renal transplantation with an approved administration dosage of 1-3 mg/kg/day. The action of MZR resembles that of mycophenolate mofetil (MMF), but MZR dosing is markedly lower than that of MMF. To examine whether higher dosin...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s10157-013-0780-1

    authors: Takahara S,Takahashi K,Akiyama T,Uchida K,Tanabe K,Amada N,Toma H

    更新日期:2013-12-01 00:00:00

  • Cystic renal cell carcinoma, suspected because of lack of regression of renal cysts after renal transplantation in a dialysis patient with acquired renal cystic disease.

    abstract::A 34-year-old man who had been on dialysis for about 6 years, and had acquired renal cystic disease, received a renal transplantation. However, in spite of the success of the transplantation, one area without cyst regression was observed in the original kidney. Therefore, carcinoma was suspected and nephrectomy was pe...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s101570300013

    authors: Ishikawa I,Saito A,Chikazawa Y,Asaka M,Tomosugi N,Yuri T,Suzuki K,Ueda Y,Ozaki M

    更新日期:2003-03-01 00:00:00

  • Epidemiology of dyslipidemia in chronic kidney disease.

    abstract::Dyslipidemia is an established risk factor for atherosclerotic disease, such as stroke and ischemic heart disease, and is often detected in patients with chronic kidney disease (CKD). The role of dyslipidemia in CKD progression, however, is not well understood. CKD patients are heterogeneous and may include those who ...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s10157-013-0891-8

    authors: Iseki K

    更新日期:2014-04-01 00:00:00

  • Anion gap predicts early mortality after starting hemodialysis in the elderly.

    abstract:BACKGROUND:Serum anion gap (AG) has recently been proven to represent a biomarker for predicting prognosis in patients with end-stage renal disease (ESRD). However, whether change in AG (ΔAG) at the time of starting hemodialysis predicts mortality after starting hemodialysis in elderly patients with ESRD remains unknow...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-019-01844-0

    authors: Arai Y,Tanaka H,Shioji S,Sakamoto E,Kondo I,Suzuki M,Katagiri D,Tada M,Hinoshita F

    更新日期:2020-05-01 00:00:00